Pathstone Holdings LLC Acquires 7,412 Shares of Encompass Health Co. (NYSE:EHC)

Pathstone Holdings LLC boosted its holdings in Encompass Health Co. (NYSE:EHC) by 54.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,022 shares of the company’s stock after purchasing an additional 7,412 shares during the period. Pathstone Holdings LLC’s holdings in Encompass Health were worth $2,032,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. UMB Bank n.a. grew its position in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC boosted its stake in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares during the period. Oakworth Capital Inc. bought a new stake in shares of Encompass Health during the second quarter valued at about $40,000. Benjamin F. Edwards & Company Inc. boosted its position in shares of Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Encompass Health during the second quarter valued at approximately $58,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE EHC opened at $103.77 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The company’s 50-day moving average is $97.28 and its 200 day moving average is $90.99. The stock has a market capitalization of $10.45 billion, a P/E ratio of 25.07, a P/E/G ratio of 1.34 and a beta of 0.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the prior year, the company earned $0.86 earnings per share. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. On average, sell-side analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.66%. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Stephens restated an “overweight” rating and issued a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Barclays boosted their target price on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. UBS Group lifted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.